Antifungal activity of different molecular weight chitosans against planktonic cells and biofilm of Sporothrix brasiliensis

Int J Biol Macromol. 2020 Jan 15:143:341-348. doi: 10.1016/j.ijbiomac.2019.12.031. Epub 2019 Dec 6.

Abstract

Sporotrichosis, caused by Sporothrix schenckii complex species, is the most prevalent subcutaneous mycosis in many areas of Latin America. Chitosan has been used as an antifungal agent; however the effects of the molecular weight (MW) of chitosan (i.e. high (HMW), medium (MMW) and low (LMW) molecular weight chitosan) on S. brasiliensis has not been well described, particularly on biofilms. Effects on the planktonic form activity of S. brasiliensis were quantified by broth microdilution, while anti-biofilm activity was quantified by measuring metabolic activity via XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide and biomass formation (crystal violet). The molecular weight of chitosan modulated its effect on the planktonic form of S. brasiliensis, presenting lower MIC values for LMW chitosan. With regards both the adhesive and mature phases of biofilm, the LMW chitosan reduced biomass and metabolic activity most effectively. This study confirms the effects of the molecular weight and deacetylation degree of chitosan on its antifungal properties for potentially pathogenic fungi.

Keywords: Biofilm; Chitosan; Sporothrix brasiliensis.

MeSH terms

  • Biofilms / drug effects*
  • Chitosan / chemistry
  • Chitosan / pharmacology*
  • Humans
  • Molecular Weight
  • Plankton / drug effects
  • Sporothrix / drug effects*
  • Sporothrix / growth & development
  • Sporotrichosis / drug therapy
  • Sporotrichosis / pathology

Substances

  • Chitosan